Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Zhonghua nei ke za zhi [Chinese journal of internal medicine] 2015-Nov

[The prognostic value of serum albumin for in-hospital mortality in patients with heart failure basing on propensity score matching].

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Veza se sprema u međuspremnik
Tongtong Yu
Jiaolei Song
Shuangshuang Liu
Chuanhe Wang
Jingjing Wang
Su Han
Zhaoqing Sun
Zhijun Sun

Ključne riječi

Sažetak

OBJECTIVE

To analyze the prognostic value of serum albumin for in-hospital mortality in patients with heart failure.

METHODS

A total of 2 430 consecutive heart failure patients aged at (68±14) years were enrolled in the study. Patients were divided into 2 groups according to serum albumin concentration on admission: the normoalbuminemia group (≥35 g/L) and the hypoalbuminemia group (<35 g/L). Propensity score matching was conducted to reduce confounding bias between the groups. Cox proportional-hazards regression models were used to evaluate the prognostic value of serum albumin for in-hospital mortality in patients with heart failure before and after matching.

RESULTS

Compared with those in the normoalbuminemia group, subjects in the hypoalbuminemia group were older, and had higher NYHA functional status and higher in-hospital mortality. More patients were diagnosed with dilated cardiomyopathy and valvular heart disease, and fewer were with hypertension in the hypoalbuminemia group than those patients in the normoalbuminemia group. Moreover, patients in this group presented with faster heart rate and lower systolic blood pressure than those in the normoalbuminemia group. They had higher levels of direct bilirubin, alkaline phosphatase, glutamyltranspetidase, creatinine, uric acid, urea, and B-type natriuretic peptide (BNP) and lower levels of hemoglobin, total cholesterol (TC), and serum sodium compared with subjects in the normoalbuminemia group. Left ventricular ejection fractions (LVEF) of patients were lower in the hypoalbuminemia group than those of patients in the normoalbuminemia group. More patients were of long-duration and treated with spirolactone. With protensity score matching, 631 pairs of patients were successfully matched. Before matching, the in-hospital mortality in normoalbuminemia group was 1.2% and that in hypoalbuminemia group was 5.7%. The multivariate Cox regression analysis indicated that the risk for in-hospital death in patients with heart failure was 12.0% greater for each 1 g/L decrement in albumin level after adjusted for all clinical factors (HR 1.120, 95% CI 1.057-1.186; P<0.001). The same held after matching. The in-hospital mortality in normoalbuminemia group was 2.9%, and that in hypoalbuminemia group was 5.7%. The multivariate Cox regression analysis showed that the risk for in-hospital death in patients with heart failure was 11.0% greater for each 1 g/L decrement in albumin level after adjusted for all clinical factors (HR 1.110, 95% CI 1.043-1.181; P=0.001).

CONCLUSIONS

Serum albuminis is an independent risk factor for in-hospital mortality in patients with heart failure. Treatment of hypoalbuminemia may lower the in-hospital mortality in patients with heart failure.

Pridružite se našoj
facebook stranici

Najkompletnija baza ljekovitog bilja potpomognuta znanošću

  • Radi na 55 jezika
  • Biljni lijekovi potpomognuti znanošću
  • Prepoznavanje bilja slikom
  • Interaktivna GPS karta - označite bilje na mjestu (uskoro)
  • Pročitajte znanstvene publikacije povezane s vašom pretragom
  • Pretražite ljekovito bilje po učincima
  • Organizirajte svoje interese i budite u toku s istraživanjem vijesti, kliničkim ispitivanjima i patentima

Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Svi podaci temelje se na objavljenim znanstvenim istraživanjima

Google Play badgeApp Store badge